PHE influenza immunisation 2020/21 guideline
While influenza is usually a self-limiting infection (with most cases concentrated into an eight- to 10-week period during the winter), the virus can still cause significant distress or mortality particularly in vulnerable patients, such as those who are immunosuppressed or have concurrent conditions like chronic neurological disease or are morbidly obese. Vaccination against influenza has been recommended since the late 1960s in order to protect those most at risk.
This updated Guidelines summary covers at-risk groups in need of vaccination, how and when to administer a vaccination, and an amended table of availability for vaccines. It includes information the expansion of the programme for the 2020/21 flu season.